SCHEMBL15039490

SCHEMBL15039490

O=C1C=C(Nc2ccccc2)/C(=N\c2ccc(O)cc2)C=C1Nc1ccc(O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.61
RAB9A P51151 7/20 0.50
MAPT P10636 7/20 0.50
BLM P54132 5/20 0.50
MAPK1 P28482 4/20 0.50
TDP1 Q9NUW8 4/20 0.50
JAK2 O60674 1/20 0.50
EPHB2 P29323 1/20 0.50
S100B P04271 1/20 0.43
NPC1 O15118 6/20 0.41
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
L3MBTL1 Q9Y468 5/20 0.41
HTT P42858 5/20 0.41
APAF1 O14727 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 4/20 0.41
LMNA P02545 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
CASP3 P42574 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15020366 1.00 DNM1 (0.61) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL15020365 1.00 DNM1 (0.61) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL15020045 0.94 DNM1 (0.69) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL15020041 0.94 DNM1 (0.69) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL15039495 0.94 DNM1 (0.69) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL5509707 0.88 MAPT (0.47) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL5509711 0.88 MAPT (0.47) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL15019784 0.88 DNM1 (0.59) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL15019783 0.88 DNM1 (0.59) DNM1RAB9AMAPTBLMMAPK1
SCHEMBL15039496 0.88 DNM1 (0.59) DNM1RAB9AMAPTBLMMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9554977-B2 Triaromatic azomethine direct dyes, dye composition comprising at least one such dye, method of implementation and use L'OREAL (FR) 2017-01-31 US disclosed
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2015-11-12 US disclosed
WO-2013087768-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2013-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE KRT18, MKI67, CDC73 DNM1 2808/4885RAB9A 4589/4885MAPT 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.